中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2008年
5期
711-712
,共2页
心肌梗死%心房颤动%卡托普利%胺碘酮
心肌梗死%心房顫動%卡託普利%胺碘酮
심기경사%심방전동%잡탁보리%알전동
Acute myocardial infarction%Atrial fibrillation%Amiodarone%Captopril
目的 探讨卡托普利联合胺碘酮治疗急性心肌梗死并发心房颤动的疗效.方法 急性心肌梗死并发心房颤动62例分两组,治疗组予以卡托普利联合胺碘酮治疗,对照组予以普罗帕酮治疗,比较24h心房颤动转复率、心房颤动发作控制(减少心房颤动发作60%以上)率、充血性心力衰竭发生率、再梗死率、住院期间死亡率、1年后死亡率、1年内脑卒中发生率.结果 治疗组能控制心房颤动发作(减少心房颤动发作60%以上),维持窦性心律,与对照组相比,再梗死率(6.3%与16.7%)、死亡率(9.4%与16.7%)、充血性心力衰竭发生率(9.4%与30.0%)、脑卒中发生率(3.1%与13.3%),均明显降低(均P<0.01).结论 卡托普利联合胺碘酮治疗急性心肌梗死并发心房颤动疗效确切、安全,患者多方面受益,值得推广应用.
目的 探討卡託普利聯閤胺碘酮治療急性心肌梗死併髮心房顫動的療效.方法 急性心肌梗死併髮心房顫動62例分兩組,治療組予以卡託普利聯閤胺碘酮治療,對照組予以普囉帕酮治療,比較24h心房顫動轉複率、心房顫動髮作控製(減少心房顫動髮作60%以上)率、充血性心力衰竭髮生率、再梗死率、住院期間死亡率、1年後死亡率、1年內腦卒中髮生率.結果 治療組能控製心房顫動髮作(減少心房顫動髮作60%以上),維持竇性心律,與對照組相比,再梗死率(6.3%與16.7%)、死亡率(9.4%與16.7%)、充血性心力衰竭髮生率(9.4%與30.0%)、腦卒中髮生率(3.1%與13.3%),均明顯降低(均P<0.01).結論 卡託普利聯閤胺碘酮治療急性心肌梗死併髮心房顫動療效確切、安全,患者多方麵受益,值得推廣應用.
목적 탐토잡탁보리연합알전동치료급성심기경사병발심방전동적료효.방법 급성심기경사병발심방전동62례분량조,치료조여이잡탁보리연합알전동치료,대조조여이보라파동치료,비교24h심방전동전복솔、심방전동발작공제(감소심방전동발작60%이상)솔、충혈성심력쇠갈발생솔、재경사솔、주원기간사망솔、1년후사망솔、1년내뇌졸중발생솔.결과 치료조능공제심방전동발작(감소심방전동발작60%이상),유지두성심률,여대조조상비,재경사솔(6.3%여16.7%)、사망솔(9.4%여16.7%)、충혈성심력쇠갈발생솔(9.4%여30.0%)、뇌졸중발생솔(3.1%여13.3%),균명현강저(균P<0.01).결론 잡탁보리연합알전동치료급성심기경사병발심방전동료효학절、안전,환자다방면수익,치득추엄응용.
Objective To approach therapeutic effect of captopril combined with amiodarone in treating acute myocardial infarction complicating atrial fibrillatio. Methods Select acute myocardial infarction complicating atrial fibrillatio 62 patients, divide into two groups, therapy bundle offer captopril combine amiodarone, control bundle offer propafenone, compare rate of atrial fibrillatio turn over with 24 houres, control rate of atrial fibrillatio attack (reduce atrial fibrillatio attacking over 60%), tetain sinus rhythn, backward heart failure incidence rate, repeated infarct rate, hospitalization death rate, death rate one year later, stroke incidence rate within one year. Results Captopril combined with amiodarone in treating acute myocardial infarction complicating atrial fibrillatio, it can turn over atrial fibrillatio utility, control atrial fibrillatio attack (reduce atrial fibrillatio attacking over 60%), reduce repeated infarct rate (6.3% vs 16.7%), death rate (9.4% vs 16.7%), backward heart failure incidence rate (9.4% vs 30.0%), stroke incidence rate (3.1% vs 13.3%)(all P<0.01). Conclusions The therapeutic effect is certain about captopril combine amiodarone in treating acute myocardial infarction complicating atrial fibrillatio. And this method is safety. The patient profit from it in many ways. It deserves generalization and application.
